List of Contents

Blood Clot Retrieval Devices Market Size, Share, and Trends 2024 to 2034

Blood Clot Retrieval Devices Market (By Stroke Type: Ischemic Stroke (blood clot), Hemorrhagic Stroke (rupturing of arteries), Transient Ischemic Attack; By Device Type: Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Aspiration Device, Ultrasound Assisted Devices; By Application: Coronary Arteries, Peripheral Arteries, Cerebral Arteries; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032

  • Last Updated : September 2023
  • Report Code : 1808
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Clot Retrieval Devices Market 

5.1. COVID-19 Landscape: Blood Clot Retrieval Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Clot Retrieval Devices Market, By Stroke

8.1. Blood Clot Retrieval Devices Market, by Stroke, 2023-2032

8.1.1. Ischemic Stroke (blood clot)

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Hemorrhagic Stroke (rupturing of arteries)

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Transient Ischemic Attack

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Blood Clot Retrieval Devices Market, By Devices

9.1. Blood Clot Retrieval Devices Market, by Devices, 2023-2032

9.1.1. Mechanical Embolus Removal Devices

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Penumbra Blood Clot Retrieval Devices

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Stent Retrievers

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Aspiration Device

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Ultrasound Assisted Devices

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Blood Clot Retrieval Devices Market, By Application 

10.1. Blood Clot Retrieval Devices Market, by Application, 2023-2032

10.1.1. Coronary Arteries

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Peripheral Arteries

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Cerebral Arteries

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Blood Clot Retrieval Devices Market, By End User 

11.1. Blood Clot Retrieval Devices Market, by End User, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Diagnostic Centers

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Clinics

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Blood Clot Retrieval Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.1.2. Market Revenue and Forecast, by Devices (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Devices (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.2.2. Market Revenue and Forecast, by Devices (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Devices (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Devices (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Devices (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.3.2. Market Revenue and Forecast, by Devices (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Devices (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Devices (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Devices (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.4.2. Market Revenue and Forecast, by Devices (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Devices (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Devices (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Devices (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Devices (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Stroke (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Devices (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. AngioDynamics

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Terumo Co.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Johnson and Johnson

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. ECKOS Co.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Bayer HealthCare LLC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Boston Scientific Co.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Argon Medical Devices

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Medtronic Plc

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Teleflex Incorporated

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Penumbra

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client